Train Babcock Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$215K Sell
3,502
-1,014
-22% -$63.4K 0.09% 91
2017
Q3
$288K Sell
4,516
-561
-11% -$32.8K 0.16% 69
2017
Q2
$283K Sell
5,077
-481
-9% -$26.2K 0.12% 93
2017
Q1
$302K Sell
5,558
-3,475
-38% -$191K 0.14% 88
2016
Q4
$528K Buy
9,033
+25
+0.3% +$1.37K 0.22% 77
2016
Q3
$486K Buy
9,008
+210
+2% +$13.5K 0.2% 83
2016
Q2
$647K Hold
8,798
0.26% 74
2016
Q1
$562K Hold
8,798
0.22% 77
2015
Q4
$605K Sell
8,798
-1,504
-15% -$99.4K 0.23% 78
2015
Q3
$610K Hold
10,302
0.22% 79
2015
Q2
$685K Buy
10,302
+152
+1% +$10K 0.22% 80
2015
Q1
$655K Hold
10,150
0.21% 84
2014
Q4
$599K Sell
10,150
-2,500
-20% -$141K 0.19% 86
2014
Q3
$647K Sell
12,650
-1,700
-12% -$84.9K 0.22% 82
2014
Q2
$696K Buy
14,350
+1,500
+12% +$73.9K 0.23% 81
2014
Q1
$668K Sell
12,850
-500
-4% -$26.6K 0.21% 82
2013
Q4
$710K Sell
13,350
-138
-1% -$7.03K 0.25% 75
2013
Q3
$624K Sell
13,488
-350
-3% -$15.4K 0.23% 75
2013
Q2
$618K Buy
+13,838
New +$601K 0.23% 71

Other funds holding BMY

Train Babcock Advisors's BMY Position: Q4 2017 in Review

Train Babcock Advisors reduced its Bristol-Myers Squibb (BMY) stake by 22% in Q4 2017, selling an estimated $63.4K and leaving 3,502 shares worth $215K. The position accounts for 0.09% of the portfolio, ranked #91.

Train Babcock Advisors first reported a position in BMY in Q2 2013 and has held it in 19 quarters since. The position peaked at $710K in Q4 2013. 1,736 funds tracked by Wall St. Rank hold BMY as of Q4 2017.

  • Train Babcock Advisors held 3,502 shares of Bristol-Myers Squibb worth $215K as of Q4 2017.
  • Train Babcock Advisors sold 1,014 Bristol-Myers Squibb shares in Q4 2017, an estimated $63.4K.
  • Bristol-Myers Squibb made up 0.09% of Train Babcock Advisors's portfolio in Q4 2017, its #91 holding.
  • Train Babcock Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 19 quarters since.
  • Train Babcock Advisors's Bristol-Myers Squibb position peaked at $710K in Q4 2013.
  • 1,736 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.

Based on Train Babcock Advisors's 13F filing for Q4 2017, filed 10 Jan 2018.